Back
NewLake Capital Partners Vs. Corbus Pharmaceuticals Holdings Industry Stock Comparison
Buy
75
NLCP
NewLake Capital Partners
Last Price:
20.58
Seasonality Move:
-3.25%
Buy
62
CRBP
Corbus Pharmaceuticals Holdings
Last Price:
45.76
Seasonality Move:
-8.14%
Buy
75
NewLake Capital Partners (NLCP)
is a Buy
Is NewLake Capital Partners a Buy, Sell or Hold?
- The current NewLake Capital Partners [NLCP] share price is $20.55. The Score for NLCP is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- NLCP is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Corbus Pharmaceuticals Holdings (CRBP)
is a Buy
Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?
- The current Corbus Pharmaceuticals Holdings [CRBP] share price is $44.14. The Score for CRBP is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- CRBP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NLCP Stock Price Chart
What is NewLake Capital Partners's stock price today?
-
The NewLake Capital Partners share price today is $20.55
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NLCP is experiencing slight buying pressure.
CRBP Stock Price Chart
What is Corbus Pharmaceuticals Holdings's stock price today?
-
The Corbus Pharmaceuticals Holdings share price today is $44.14
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRBP is experiencing slight selling pressure.
NLCP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.63 | Buy |
| Relative Strength Index (14 RSI): | 70.73 | Buy |
| Chaikin Money Flow: | 17826 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.12 - 20.14) | Buy |
| Bollinger Bands (100): | (16.03 - 18.83) | Buy |
CRBP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.63 | Buy |
| Relative Strength Index (14 RSI): | 64.96 | Buy |
| Chaikin Money Flow: | -124400 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.22 - 42.24) | Buy |
| Bollinger Bands (100): | (14.78 - 41.78) | Buy |
NLCP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.36 | Buy |
| 20-day SMA: | 19.39 | Buy |
| 50-day SMA: | 18.51 | Buy |
| 200-day SMA: | 15.39 | Buy |
| 8-day EMA: | 20.25 | Buy |
| 20-day EMA: | 19.63 | Buy |
| 50-day EMA: | 18.64 | Buy |
| 200-day EMA: | 16.38 | Buy |
CRBP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 42.2 | Buy |
| 20-day SMA: | 38.94 | Buy |
| 50-day SMA: | 39.41 | Buy |
| 200-day SMA: | 17.1 | Buy |
| 8-day EMA: | 42.17 | Buy |
| 20-day EMA: | 40.25 | Buy |
| 50-day EMA: | 36.89 | Buy |
| 200-day EMA: | 22.3 | Buy |
NewLake Capital Partners Earnings Growth & NLCP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.00 per share.
Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.55 per share, an increase next quarter of $0.28 per share, an increase this year of $5.53 per share, and an increase next year of $0.35 per share.
NewLake Capital Partners Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corbus Pharmaceuticals Holdings Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||